Annexon Bio Brings On Rheos Exec Sanjay Keswani as Chief Medical Officer

Frank Vinluan

July 11th, 2019

Sanjay Keswani has left the president and CEO post at Rheos Medicines to become chief medical officer of Annexon Biosciences. Keswani’s experience also includes positions at Roche, Bristol-Myers Squibb (NYSE: BMY), and Eli Lilly (NYSE: LLY). In other moves, South San Francisco-based Annexon named Jennifer Lew chief financial officer and Lesley Stolz chief business officer. Annexon is developing drugs to treat autoimmune and neurodegenerative diseases.

Frank Vinluan is an Xconomy editor based in Research Triangle Park. You can reach him at fvinluan [[at]] xconomy.com. Follow @frankvinluan